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ABSTRACT
A propensity to experience psychological distress and their expression in the form of somatic symptoms and to seek medical
help for them is called Somatization. It is basically an inception of some psychiatric conditions like Affective Disorders (anxiety and 
depression) and Somatoform Disorders. A Somatoform Disorder is a category of mental disorder in which physical symptoms
that suggest physical condition or injury cannot be explained fully by a general medical condition. This possibility must always be 
considered when patient has recurring somatic complaints for at least six months. Depression and Somatic Symptoms Disorder can 
easily be recognized when they present separately or in association with each other. But the main hurdle is to develop a holistic 
approach and strategy to not be misguided by the intimidating nature of presenting physical symptoms. For that detailed evaluation 
should be carried out and every single possibility along with somatization should be kept under consideration, which would enable to 
recognize and treat the illness earlier and save considerable amount of time and resources as well.
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INTRODUCTION
Somatization is the expression of psychological 
distress in the form of physical symptoms leading
the patient to seek medical help [1]. It is basically
an inception of psychiatric conditions like affective 
disorders (anxiety and depression) and somatoform 
disorders. A somatoform disorder is a category of 
mental disorder in which there are debilitating
physical symptoms in the patient that cannot be fully 
explained by any general medical condition or effect
of any substance, and are not related to any other
mental disorder. The latest version DSM-5 has
combined somatization disorder with somatoform 
disorder to become somatic symptom disorder [1]. 
People who have been diagnosed with a somatic 
symptom disorder, their medical test results are
either normal or are non contributory, and the history 
and physical examinations do not suggest the
presence of any known medical condition, though it is 
important to note that the DSM-5 cautions that this 
alone is not sufficient for diagnosis. The patient must 
also be excessively worried about these symptoms, 
and the worry must be out of proportion to the severity 
of the physical symptoms. This diagnosis can
only be considered if the patient has recurring
somatic complaints for at least six months. Following 
case describes a patient with severe depression
and suicidal thoughts; he was brought to the
medical facility by his wife after his symptoms
became unbearable.
CASE REPORT
A 70 years old married, retired male known case of
hypertension, gastro esophageal reflux, chronic
headaches and chronic prostatitis admitted to the hospital 
with presenting complaints of low mood, suicidal thoughts 
and chronic headache. He had become increasingly 
depressed due to these disabling headaches and thought 
about ending his life by overdosing with drugs.
 
The patient had never been treated by a psychiatrist in 
the past. He had headaches for almost 14 years and 
gone through a lot of workup for his headaches, sought 
neurological advice in the past, but they have not been 
able to find any contributing factors. He has been
on different medications including Paroxetine and 
Amitriptyline, both of which were non effective.
Moreover, Amitriptyline was also discontinued due to its 
urinary side effects making his chronic prostatitis worse.
MENTAL STATE EXAMINATION AT THE 
TIME OF ADMISSION
Patient was cooperative with fair eye contact, mood was 
depressed (I don’t want to live with this headache), 
affect was appropriate. He appeared to be anxious. Past 
and recent memory was intact. He denied suicidal
ideation but had thoughts to end his life to get rid of his 
pain; he was alert and oriented with time, place and 
person. Judgment and insight were limited. Intellect was 
average.
On further investigation and a meeting with his wife 
revealed that this has been going on for a long time and 
that his life has come to a standstill. He does not go out 
much because of these headaches, had been visiting so
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many pain clinics and had many consultations with 
various specialists including a neurologist. The baseline
investigations including EKGs, blood sugars, lipid profile, 
metabolic panel and some specialized investigations like 
MRI Brain as suggested by neurophysician were all within 
normal limits. It was found that he didn`t have any actual 
headaches, rather had fear of having headaches.
He used to take Tramadol three times a day along with 
Alprazolam for a very long time, but stopped taking them 
because of fear of upsetting his stomach. So, it seemed 
that everything focus down to fear, rather than an actual 
problem. The treatment plan was discussed with the 
patient and his wife in detail. According to the patient he 
had used so many antidepressants as prescribed by
his primary care physician. He was started initially on 
Duloxetine, and then changed to Sertraline whose dose 
was gradually increased to avoid any somatic complaints. 
Aripiprazole was also added to the regimen for the 
concern of his underlying somatic delusion that had been 
so disabling as well as to augment psychotropic effects. 
The patient was also provided individual and group
therapy. He was monitored closely for his suicidal
tendencies. He remained isolated but had become much 
more animated and talkative which was a big change for 
his family, he was compliant with medications as well. As 
patient was not suicidal he was discharged in custody of 
his wife after 10 days with the impression of 1. major 
depression recurrent; 2. somatoform disorder; 3. somatic 
delusional disorder. Discharge medications were
Alprazolam 0.5 mg t.i.d., Sertraline 50mg twice a day, 
Aripiprazole 5 mg half a tablet twice a day, Zolpidem CR 
6.25 mg at night, with a follow up plan of two weeks.
On follow up, he was found to have severe headaches 
and severely depressed mood, thus, an alteration in 
medications was done. Alprazolam was decreased to 
0.25 mg and Aripiprazole bumped up to 15 mg, but still 
the condition was not improved. Sertraline was put on 
hold for three days keeping side effect profile in mind. 
On next follow up patient’s mood was somewhat better 
and there was a slight improvement in headaches as 
well. Aripiprazole was then decreased to 7.5 mg and 
reassurance was provided. Overall condition was stable 
from then onwards but on next follow up after a month, 
patient appeared to be anxious and depressed again 
though headaches were better than before but had 
developed many obsessive and somatic concerns like 
mowing the lawn again and again and sun shades
causing him headaches. Olanzapine 2.5 mg HS was 
started then, and option for ECT was discussed and a 
neurological consult was also generated. Patient was 
also prescribed Venlafaxine XR 75 mg AM and
afternoon and Divalproex ER 250 mg BID with follow up 
after a month. Patient’s wife called after 4 days due to 
worsening of anxiety and irritability. Divalproex was 
discontinued and Olanzapine was increased to 10 mg
HS and 2.5 mg AM, with further plan to tape
Venlafaxine. On next follow up after a month, his
condition started worsening. He started complaining of 
excessive worries, obsessing thoughts about finances, 
not feeling well and had lost almost 20 lbs weight. The 
option of ECT was discussed and Venlafaxine was 
discontinued as the patient had also developed
constipation, Citalopram 20 mg daily was added to the 
regimen and AM dose of Olanzapine was kept on hold, 
although 10 mg HS dose was continued so that it could 
help him sleep. As his condition was not getting any 
better, ECT was started. After 2 months and 7 sessions 
of ECT, patient’s condition was improved. He became 
euthymic, headaches and anxiety were gone. He even 
visited his daughter who lived in London. Citalopram 
was then increased to 40 mg and Olanzapine decreased 
to 5 mg HS, and planned to decrease it in following 7-8 
months. After 18 months Olanzapine was reduced to 2.5 
mg HS, patient was stable during this period and there 
were no active complaints. But again after 10 more 
months they visited Europe where his condition started 
worsening, headaches returned, had episodes of
shortness of breath, started to express excessive 
worries and fears and went downhill. They shortened 
their trip and came back. On further investigation, it was 
found that his sleep was decreased, lost 12 lbs weight, 
mood extremely depressed, latency of response and 
psychomotor retardation was also developed. Thus, the 
dose of Olanzapine was increased to 2.5 mg AM and 5 
mg HS and pre ECT work up was advised. 7 sessions 
were given then, Olanzapine 10mg HS was started two 
days before scheduled ECT which was tapered back to 
5 mg on the day of 4th ECT.  After 6 months, patient 
became euthymic again and gained 15 lbs weight. 
Because of this, morning dose of Olanzapine was 
stopped. In the following 12 months patient underwent 
cardiac catheterization. During this period Olanzapine 
was decreased to 2.5 mg HS. But again he started
complaining of headaches. He had been taking Fioriceit 
3-4 times a day. He was suggested to keep a calendar 
of his headaches. A month later there were no
improvements in headache, energy was decreased as 
well as mood. He visited a neurologist again,
reassurance was provided and was advised to consider 
ECT again if headaches become unbearable. 3 months 
later after completing cardiac rehabilitation patient had 
some improvement in headaches but had lost 8 lbs 
weight. He was prescribed Topiramate 25 mg daily, 
other medications were continued. After 6 months 
patient still had headaches but only in frontal region, 
temporal sides were relieved. The dose of Topiramate 
was increased up to 75mg but frontal pain was not 
relieved. So, the dose was tapered back to 25 mg.
A stress test was also done and was found to be normal. 
Within next 24 months patient’s condition was gradually 
improved, he was alert, calm, sleep was normal,
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appetite and drug compliance was good. Headaches 
had vanished along with improvement in mood
symptoms and stress. After few more follow ups
Citalopram was then brought down to 20 mg and he had 
been doing well since then.
DISCUSSION
This case is a typical presentation of somatic symptom 
disorder associated with depression [2], the patient had 
low mood and history of chronic headaches, which 
remained unexplained even though extensive workup 
had been carried out. Further there is significant
association of these headaches with depression i.e. 
whenever his depression goes in to remission his
physical symptoms improved noticeably [3]. As it has 
been observed that during the overall course of the 
disease patient has gone through various episodes of 
remission and relapse. Whenever there was some 
stressors in his life, he started complaining of
headaches. Though the medications he was taking was 
not for actual headaches but the fear that those
headaches would return [4]. They were so disabling that 
he had thoughts about ending his life in order to get rid 
of his symptoms.
This not very common association can lead to biased 
approach not only by primary health care physicians but 
psychiatrists as well. Thus, may cause delay in
treatment and unnecessary consultations with
various specialties [5]. The result of which could be 
misdiagnosis and wastage of funds and resources. 
Various studies have been conducted in order to 
analyze this cost benefit relation among patients with 
somatoform disorders, which have clearly shown that 
results are not favorable, have raised many questions in 
this regard, and emphasize the need to determine the 
independence and overlap between the somatic and 
psychiatric disorders in order to have a better idea about 
dynamics of the condition [5, 6]. Thus, whenever a 
depressed patient presents with typical somatic
symptoms, this possibility could always be kept in mind 
with reference to its overall prevalence [7, 8].
Further, a psychiatrist must discuss the diagnosis in 
proper detail as well as proper counseling should be 
done to let the patient understand severity of their 
mental illness apart from physical complaints which they 
are facing. Various options available should be 
discussed, as the condition which is active makes 
patient unable to realize the exact root cause [9]. 
This is not the case with patients only; two studies were 
conducted in 1985 and 1993 in which more than 50% 
and 78% cases were misdiagnosed respectively due to 
somatization [10, 11]. In routine practice there are 
always some issues which are needed to be discussed
both by physician and patient, and every single thing 
can’t be settled out in one go, for which follow ups are 
being scheduled. In cases of depression in which 
somatic symptoms are much more dominant, makes it 
difficult for physician to consider psychiatric illness as a 
diagnosis due to masking by more active somatic
complaints. It might be due to severity of complains with 
which the patient presents but the liability on physicians 
side cannot be ignored as well, a lot of time they are due 
to minor negligence in understanding the psychological 
symptoms expressed by patients [12].
Thus, whenever a case present with symptoms which 
are medically unexplained, a primary health care
physician should keep a vigilant approach and always 
keep depression at one of the top most differentials. In 
this regards some arrangements must be carried out to 
raise awareness regarding typical and atypical
presentations of depression and the list of somatic 
symptoms e.g. headaches, backaches, generalized 
body aches associated with it. An important attribute 
which must be enlightened here is that improvement in 
communication and consulting skills in primary care in 
accordance with case relevance would also be fairly 
useful.
CONCLUSION
Depression and somatic symptoms disorder can easily 
be recognized when they present separately or in
association with each other. But the main hurdle is
to develop a holistic approach and strategy to not
be misguided by the intimidating nature of presenting
physical symptoms. For that, detailed evaluation 
should be carried out and every single possibility 
should be kept under consideration, which would 
enable to recognize and treat the illness earlier and 
save considerable amount of time and resources
as well. 
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